Skip to Content

Interferon Alfacon-1

In the US, Interferon Alfacon-1 (interferon alfacon-1 systemic) is a member of the drug class interferons and is used to treat Hepatitis C.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L03AB,L03AB09

CAS registry number (Chemical Abstracts Service)

0118390-30-0

Chemical Formula

C870-H1366-N236-O259-S9

Molecular Weight

19567

Therapeutic Categories

Antiviral agent

Biological response modifier, BRM

Immunomodulator

Antiviral agent: Treatment of hepatitis C

Chemical Name

N-L-Metionyl-22-L-arginine-76-L-alanine-78-L-aspartic acid-79-L-glutamic acid-86-L-tyrosine-90-L-tyrosine-156-L-treonine-157-L-asparagine-158-L-leucineinterferon alpha1 (human lymphoblast reduced) (WHO)

Foreign Names

  • Interferonum alfacon-1 (Latin)
  • Interferon alfacon-1 (German)
  • Interféron alfacon-1 (French)
  • Interferón alfacon-1 (Spanish)

Generic Names

Brand Names

  • Infergen
    Astellas, China; Closter, Colombia; IFET, Greece; Yamanouchi, Greece

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide